Learning Objectives: Upon finishing this course, the participants will be able to
A. Differentiate the mimickers of benign tumors of the breast.
B. Review the strategies and useful tips for diagnosing mucinous carcinoma.
C. Accurately classify papillary breast lesions.
D. Recognize the pitfalls of diagnosing spindle cell neoplasms of the breast.
Date: Sun. April 11, 2021
Registration is complimentary.
RSVP before March 21, 2021 at http://bit.do/8pips (google based, may need to open on your mobile device or home PC)
Location: Virtual via Zoom.
Course material (NA)
8:50- 9:00 am Opening Remarks. Lanjing “L.J.” Zhang, Princeton Medical Center/Rutgers and Puay Hoon Tan, Singapore General Hospital
9:00- 9:30 am Spindle cell lesions of the breast – a diagnostic approach. Gary Tse, Chinese University of Hong Kong
9:30-10:00 am Correlation of radiology and breast pathology. Li Fu, Tianjin Cancer Center, China
10:00-10:30 am External Quality Assurance for Molecular Pathology and Immunohistochemistry. Ian Cree, International Agency for Research on Cancer, France
Morning break (10:30-10:50 am)
10:50-11:20 am WHO 2019 classification of papillary breast lesions. Edi Brogi, Memorial Sloan Kettering Cancer Center
11:20-11:50 am The pathologic spectrum of mucinous lesions of the breast. Juan Palazzo, Baptist Hospital of Miami
11:50-12:20 pm Molecular classification of breast cancer – relevance and challenges. Xinmin Zhang, Cooper University Hospital/Rowan University
12:20-12:35 pm Q&A session
Lunch break (12:35-1:00 pm)
1:00-1:30 pm Malignant breast lesions mimicking benignity – staying out of trouble. Kimberly H. Allison, Stanford University School of Medicine
1:30-2:00 pm Phyllodes tumors of the breast – diagnostic challenges. Ping Tang, Loyola University Medical Center
2:00-2:30 pm Benign breast lesions mimicking malignancy – avoiding landmines. Ira Bleiweiss, Hospital of the University of Pennsylvania
Afternoon break (2:30-2:45 pm)
2:45-3:15 pm Uncommon types of breast carcinoma. Shi Wei, University of Alabama at Birmingham
3:15-3:45 pm Diagnosis of ductal carcinoma in situ in the era of de-escalation of therapy. Stuart J. Schnitt, Brigham and Women’s Hospital, DFCI, and Harvard Medical School
3:45 -4:00 pm Q&A session
4:00-5:00 pm Networking session
Penn Medicine Princeton Health is accredited by the Medical Society of New Jersey to provide continuing medical education for physicians. Penn Medicine Princeton Health designates this live activity for a maximum of six (6) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
If you have a disability that may require special assistance, please contact Janis Puleio, CME Coordinator at (609) 853-7450.
Sponsors (alphabetical order)
Aurora Diagnostics
New Jersey Institute of Medicine, LLC
Neogenomics
Princeton Medical Center